Claire Roddie, MD, PhD, is a Consultant Haematologist at the University College London Hospitals NHS Foundation Trust, London, UK, and Honorary Senior Lecturer in Haematology at University College London, London, UK. Her main research interest is cellular therapies, primarily chimeric antigen receptor (CAR) T-cell therapy for the treatment of hematologic malignancies. Her recent involvements include publications on the clinical outcomes and risk factors for COVID-19 in patients with hematological disorders, and she is currently leading the Phase I CAROUSEL trial (NCT04443829) on CD19-targeting CAR T-cells for relapsed/refractory primary CNS lymphoma.
